Xeris Biopharma Holdings, Inc. (XERS)
6.53
-0.10
(-1.51%)
USD |
NASDAQ |
May 08, 16:00
6.53
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Shareholders Equity (Quarterly) : 13.01M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zoetis, Inc. | 3.233B |
| Harrow, Inc. | 52.45M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 392.01M |
| Total Liabilities (Quarterly) | 379.00M |
| Debt to Equity Ratio | 19.87 |
| Current Ratio | 2.122 |
| Net Debt Paydown Yield | 0.26% |